You have 9 free searches left this month | for more free features.

Neuroendocrine Carcinoma

Showing 1 - 25 of 7,344

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Large-Cell Neuroendocrine Carcinoma Trial in Lexington (Treatment Specific for Non-Small Cell Carcinoma/Adenocarcinoma,

Recruiting
  • Large-Cell Neuroendocrine Carcinoma
  • Treatment Specific for Non-Small Cell Carcinoma/Adenocarcinoma
  • Treatment for Small Cell Lung Cancer
  • Lexington, Kentucky
    Markey Cancer Center, University of Kentucky
Jan 12, 2022

Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Beijing, Xiamen, Harbin (Chidamide, Etoposide + Cisplatin/Carboplatin)

Recruiting
  • Neuroendocrine Tumors
  • Neuroendocrine Carcinoma
  • Beijing, Beijing, China
  • +2 more
Nov 2, 2021

Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)

Active, not recruiting
  • Oncology
  • Neuroendocrine Carcinoma
  • Liposomal Irinotecan
  • +3 more
  • Glasgow, United Kingdom
  • +3 more
Feb 3, 2022

Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

Not yet recruiting
  • Small-cell Lung Cancer
  • Neuroendocrine Carcinoma
  • (no location specified)
Jun 13, 2022

Neuroendocrine Carcinoma Trial in Beijing (Nab-paclitaxel Combined With Bevacizumab)

Recruiting
  • Neuroendocrine Carcinoma
  • Nab-paclitaxel Combined With Bevacizumab
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jan 9, 2021

Poorly Differentiated Malignant Neuroendocrine Carcinoma, Neuroendocrine Carcinoma, Grade 3, Neuroendocrine Carcinoma, Grade 1

Completed
  • Poorly Differentiated Malignant Neuroendocrine Carcinoma
  • +4 more
  • Everolimus (Afinitor®)
  • Berlin, Germany
    Charité-Universitätsmedizin, Medizinische Klinik m. S. Hepatolog
Oct 27, 2020

Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • Unresectable Pancreatic Neuroendocrine Carcinoma
  • Lutetium Lu 177 Dotatate
  • +4 more
  • (no location specified)
Feb 10, 2022

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Pancreas Tumor Trial in Roma, Rome (EUS guided radiofrequency ablation)

Recruiting
  • Neuroendocrine Tumors
  • +3 more
  • EUS guided radiofrequency ablation
  • Roma, RM, Italy
  • +1 more
Feb 10, 2022

Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)

Recruiting
  • Small Cell Neuroendocrine Carcinoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Mar 21, 2022

Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized

Enrolling by invitation
  • Breast Cancer
  • +3 more
  • Copenhagen, Denmark
    Rigshospitalet
May 24, 2022

Merkel Cell Carcinoma, Neuroendocrine Carcinoma of the Skin, Trabecular Carcinoma of the Skin Trial in Tampa (Lenvatinib Oral

Recruiting
  • Merkel Cell Carcinoma
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jul 27, 2022

Patients With Neuroendocrine Cancer of the Cervix

Recruiting
  • Cervical Large Cell Neuroendocrine Carcinoma
  • +21 more
  • Follow-Up
  • Medical Chart Review
  • Houston, Texas
    M D Anderson Cancer Center
May 25, 2022

Neuroendocrine Carcinoma Trial in France (Nivolumab, Ipilimumab)

Active, not recruiting
  • Neuroendocrine Carcinoma
  • Aix-en-Provence, France
  • +6 more
Mar 9, 2022

Neuroendocrine Carcinoma Trial in France (FOLFOXIRI Protocol, Cisplatin injection)

Recruiting
  • Neuroendocrine Carcinoma
  • FOLFOXIRI Protocol
  • Cisplatin injection
  • Caen, France
  • +5 more
Apr 13, 2021

Pancreatic Cancer Dietary Assessment Study

Completed
  • Pancreatic Neoplasm
  • +3 more
  • Pancreo-KIT breath test
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Feb 1, 2022

Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)

Recruiting
  • Pulmonary Neuroendocrine Neoplasm
  • +9 more
  • Houston, Texas
    Excel Diagnostics and Nuclear Oncology Center
Jul 9, 2021

Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

Recruiting
  • Neuroendocrine Tumors
  • Carcinoma, Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 6, 2022

    Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Germany (Cabozantinib)

    Recruiting
    • Neuroendocrine Tumors
    • Neuroendocrine Carcinoma
    • Göttingen, Lower Saxony, Germany
    • +5 more
    Jun 27, 2022

    Neuroendocrine Carcinoma Trial in Los Angeles (68Ga-DOTATATE)

    Completed
    • Neuroendocrine Carcinoma
    • Los Angeles, California
      University of California Los Angeles, Nuclear Medicine Clinic of
    May 12, 2021

    Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

    Recruiting
    • Small Cell Neuroendocrine Carcinoma of Bladder
    • +2 more
    • Washington, District of Columbia
    • +1 more
    Jun 27, 2022

    Neuroendocrine Tumors, Neuroendocrine Carcinoma, Temozolomide Trial in Seoul (TEMCAP)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +3 more
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Dec 13, 2020

    Lung Small Cell Carcinoma, Neuroendocrine Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Dostarlimab, Niraparib)

    Recruiting
    • Lung Small Cell Carcinoma
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 30, 2021